Orchard Therapeutics PLC -‘s (ORTX) Quiet Period To End on December 10th

Orchard Therapeutics’ (NASDAQ:ORTX) quiet period is set to expire on Monday, December 10th. Orchard Therapeutics had issued 14,285,715 shares in its IPO on October 31st. The total size of the offering was $200,000,010 based on an initial share price of $14.00. During Orchard Therapeutics’ quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

A number of equities analysts have recently commented on ORTX shares. Wedbush started coverage on shares of Orchard Therapeutics in a research report on Monday, November 26th. They set an “outperform” rating and a $25.00 target price on the stock. JPMorgan Chase & Co. started coverage on shares of Orchard Therapeutics in a research report on Monday, November 26th. They set an “overweight” rating and a $25.00 target price on the stock. Goldman Sachs Group started coverage on shares of Orchard Therapeutics in a research report on Monday, November 26th. They set a “neutral” rating and a $18.00 target price on the stock. Finally, Cowen started coverage on shares of Orchard Therapeutics in a research report on Monday, November 26th. They set an “outperform” rating and a $27.00 target price on the stock.

Shares of NASDAQ:ORTX opened at $15.06 on Monday. Orchard Therapeutics has a one year low of $13.00 and a one year high of $19.24.

ILLEGAL ACTIVITY WARNING: “Orchard Therapeutics PLC -‘s (ORTX) Quiet Period To End on December 10th” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/12/03/orchard-therapeutics-plc-s-ortx-quiet-period-to-end-on-december-10th.html.

About Orchard Therapeutics

There is no company description available for Orchard Therapeutics PLC.

Featured Article: What is a bull market?

Receive News & Ratings for Orchard Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orchard Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply